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This study examined the effects of developmental cadmium exposure on morphine- 
induced locomotor activity. Adult female rats were exposed to 0 ppm, 25 ppm and 50 ppm 
cadmium via an adulterated food source for 30 days prior to breeding. This exposure continued 
throughout gestation and for the initial 15 days of lactation. Male pups of the dams were then 
administered 10 mg/kg morphine or vehicle injections at PND 60 and locomotor activity was 
monitored. Days 1, 7, and 14 produced no separation of exposure groups. On Day 21 attenuation 
of morphine-induced behavioral sensitization was evident among animals in the 25 ppm and 50 
ppm exposure groups. Administration of dopamine D 1 receptor-type antagonist SCH 23390 
produced a dose-related decrease in locomotor activity across all groups. D2 receptor-type 
antagonist eticlopride showed no significant separation of responding among exposure groups. 
Context effects were not found to play a role in these findings. 
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The societal implications of drug abuse are incalculable. Given the magnitude of the 
problem, it is not surprising that vast amounts of research have been conducted in an attempt to 
elucidate the various physiological dynamics of drug use and addiction, and adjunctive factors 
that might alter these dynamics. Yet, one area of research that has largely been ignored is the 
possible influence of environmental pollutants on drug seeking and drug taking behaviors. Heavy 
metals, such as cadmium and lead, have been shown to alter the eflects of cocaine and morphine 
in adult rats. Self administration of cocaine increases with adult cadmium exposure (Nation, 
Livermore, Bratton ik Schenk, 1996), while the discriminitive properties of cocaine are reduced 
in animals exposed to cadmium, as demonstrated by drug discrimination studies (Nation &, 
Miller, 1999). Elsewhere it has been shown that adult cadmium exposure also produces an 
attenuation of behavioral sensitization, a heightened sensitivity to a chronically administered 
drug, induced by chronic morphine administration (Nation, Miller, ik Livermore, 1997). 
Increases in ethanol consumption also have been observed atter adult cadmium exposure. 
(Nation, Pugh, Von Schultz, Bratton k Clark, 1989). In a like manner to cadmium, lead exposure 
has been shown to produce effects similar to those described above, altering behavioral 
sensitization to cocaine (Nation, Livermore, 4k Burkey, 1996; Grover, Nation A Bratton, 1993) as 
well as the effects of ethanol consumption. (Burkey, Nation ik Bratton, 1994). 
With respect to exposure vectors of heavy metals, it is of particular interest here that 
cadmium has been shown to accumulate in tobacco leaves (Yue, 1992), which poses a particular 
risk for cadmium toxicity for smokers. This route of exposure and the extraordinarily long half- 
life of cadmium (approximately 30 years; Berman, 1980) can result in an accumulation of the 
This thesis follows the style and format of Experirnenra! and Clinical Psychopharmaeology, 
metal in the body afier repeated exposure. In fact, it has been shown that tobacco users have 
elevated blood cadmium levels relative to non-smokers and those who smoke approximately two 
pack of cigarettes per day have twice the blood cadmium levels as non-smokers (Piascik et al. , 
1985; Wu et al. , 1995). Non-tobacco users also have been shown to be at risk as a result of 
exposure to second-hand (passive) cigarette smoke (Shaham et al, 1996). And, smoking has 
been found to be prevalent among those who abuse drugs, with opiate-dependent individuals 
having an extremely high prevalence of tobacco use (Frosch, Nahom, Shoptaw tk Jarvik, 2000). 
Because of this demonstrated relation between tobacco use and drug use, it would seem 
reasonable to explore linkages between cadmium and opiates. 
Of the studies that have examined metal and drug interactions, some of the more 
compelling findings have come from behavioral sensitization studies. Behavioral sensitization 
refers to an increase in locomotor activity that is evident following chronic drug administration 
This increase in locomotor activity is thought to be the result of a supersensitivity to the drug that 
occurs with repeated administration. Of special relevance to this project, is the notion that the 
phenomenon may serve as an animal model for drug seeking and drug taking behaviors. It is 
thought that sensitization in humans could contribute to the development of drug dependence and 
addiction (Laviola, Wood, Kahn, Francis Ec Spear, 1995). Given the above discussion, it must be 
considered that cadmium exposure could lead to an alteration in the use and abuse of morphine. 
The development of behavioral sensitization is believed to occur through mechanisms of 
the nucleus accumbens (NA) and ventral tegmental area (VTA) of the brain. These areas have 
been implicated in the drug reward pathway, and it is thought that behavioral sensitization is also 
the result of altered neurorrasmitter levels in this area of the brain, though the role of the VTA in 
this pathway is still debated (Jeziorski tk White, 1995). Opiates bind to p. -opioid reoeptors 
presumably at y-aminobutyric acid (GABA) neurons of the VTA. These neurons play an 
inhibitory role in regulating dopamine (DA) firing rates in the VTA, ultimately limiting the 
amount of dopamine release in the NA. Morphine and other opiate derivatives competitively 
bind to the opioid receptor, thereby reducing GABA inhibitory action. As this loss of inhibition 
occurs, dopaminergic transmission in the VTA, and consequently dopamine availability in the 
NA, is largely uninhibited resulting in an increase in dopamine present in the NA (Julien, 1998) 
The use of dopamine antagonists lends support to the proposed role of dopamine in 
behavioral sensitization, although studies investigating the effects of the administration of 
dopamine antagonists on behavioral sensitization have not been definitive. One study found that 
administration of the D 1 receptor-type antagonist SCH 23390 resulted in an increase in 
ambulation in mice, thereby indicating an increase in the sensitivity seen with behavioral 
sensitization (Kuribara, 1995). Others, however, have shown that administration of SCH 23390 
and a D2 antagonist eticlopride result in a decrease in the heightened locomotor activity induced 
by behavioral sensitization to morphine (Jeziorski Jk White, 1995). Also of interest is that 
although the administration of dopamine antagonists such as SCH 23390 and eticlopride block 
the expression of behavioral sensitization, they do not block its development. Because 
behavioral sensitization is observed aller dopamine antagonist treatment is terminated, even if 
morphine has never been administered in the absence of the antagonist, it appears that the 
development of behavioral sensitization is dependent on p;opioid receptor stimulation. Yet, 
treatment with dopamine antagonists concurrently with morphine does not result in apparent 
increases in locomotor activity induced by behavioral sensitization. This suggests that 
stimulation of dopamine receptors is necessary for the expression of behavioral sensitization, but 
not for its development (Jeziorski Jk White, 1995). Within this context, it would be of interest to 
determine if cadmium results in differential sensitivity to dopamine antagonists SCH 23390 and 
eticlopride, indicating that the dopamine dependent pathway that results in the expression of 
increased locomotor activity due to behavioral sensitization to morphine, has somehow baca 
altered by cadmium exposure. 
Although several studies have investigated the interactions of cadmium and drugs like 
cocaine and morphine in adult rats, no studies to date have examined the possible effects of 
developmental cadmium exposure on drug behaviors later in life. Considering the 
aforementioned parallels suggested between behavioral sensitization as a laboratory phenomenon 
and drug taking and seeking behaviors, careful inspection of such possible interactions would 
seem warranted. The importance of understanding possible consequences of developmental 
cadmium exposure is underscored by the fact that 20. 4'/o of American women smoke during 
pregnancy (National Institute of Health, 1996). Because cadmium is readily transferred from the 
mother to the fetus and cadmium levels are elevated in women who smoke, the fetus of a woman 
who smokes during pregnancy is at risk for high levels of cadmium exposure. Because cadmium 
alters behavioral responses to morphine and because a neonate can be exposed to high levels of 
cadmium in utero and while nursing, it is possible that perinatal cadmium exposure (exposure 
during gestation and lactation), could result in an alteration in drug responsiveness later in life, 
Accordingly, this study was designed to investigate the efFects of perinatal cadmium exposure on 
behavioral sensitization to morphine. Additionally, antagonists SCH 23390, a Dl antagonist, and 
eticlopride, a D2 antagonist, were used to test for differential sensitivity to dopamine antagonism. 
Method 
Animals and E o ur R imen 
All aspects of the rmearch reported here were approved by the University Laboratory 
Animal Care Committee. Adult female Sprague-Dawley female rats (Charles River) were 
matched on initial body weight across groups. Each female rat was exposed to cadmium via an 
adulterated food supply. Following 30 days of exposure to their respective cadmium doses, 
females were bred to nonexposed males. Males were removed from the home cage once females 
tested positive for copulatory plugs. Females continued to receive their daily doses of cadmium 
throughout the gestational period and for the first 15 days of lactation (see below). Tap water was 
available ad libitum in the home cage. 
Litters were culled to 8 pups seven days after parturition rather than earlier to permit a 
more reliable sex determination of pups via visual inspection of genital spacing. Sixteen male 
pups from 10 dams exposed daily to 0 ppm cadmium, 13 male pups from 3 dams exposed to 25 
ppm cadmium, and 9 male pups from 1 dam exposed to 50 ppm cadmium, were included in the 
investigation. The remaining pups were used in other research projects. During the first 15 days 
of lactation, except for the day of parturition, dams continued to be exposed to their respective 
diets. The resulting procedure permitted perinatal cadmium exposure within an experimental 
framework wherein pups were unable to gain access to lead postnatally via routes other than the 
maternal milk supply. Dams were placed on standard rat chow at PND 15 to ensure that pups did 
not begin feeding on cadmium supplemented rat chow. 
On PND 21, pups were weaned and for the remainder of the study placed on ad libitum 
standard rat chow diets, and they had continuous access to a tap water supply that contained no 
added cadmium. All animals were individually housed from PND 21 until the study was 
completed. Prior to weaning, food inlake and body weight readings were recorded weekly for 
dams and pupa, and postweaning pup food intake and weight measures were recorded daily for 
the remainder of the study. 
A~~ 
The test apparatus involved an au~ Digiscan-16 system. (Omnitech Electronics, 
Inc. , Columbus, OH). Activity monitors and cages were located in a sound-proof room with a 40 
dB [SPL] white noise generator operating continuously. A multiplexor-analyzer in an adjacent 
room monitored beam breaks &om the optictd beam activity monitors and tracked the 
simultaneous interruption of beams. The multiplexor-analyzer updated the animal's position in the 
acrylic cage (40 X 40 X 30. 5 cm) every 10 ms using a 100'%%d real-time conversion system 
Computerized integration of the data obtained from the monitor afforded thc recording of general 
activity using total distance (in cm) as the dependent measure. 
Procedure 
The selection of cadmium doses was made on the basis of pilot investigations that yielded 
blood cadmium levels falling within a clinically relevant range (=35 Ng/dl or less). 
Male pups from each of the three exposure conditions (0, 25 and 50 ppm cadmium) were 
stratified according to body weight. Within given weight ranges, pupa were randomly assigned 
receive either saline or morphine injections . 
All efforts were made to place male pups from the same litter in different test conditions 
to control for possible litter effects. (cf. Holson d'z Pearce, 1992) Animals began activity testing 
on PND 60 and were randomly assigned to one of six test groups created by interacting cadmium- 
exposure condition (0, 25, 50 ppm) and type of injection (vehicle, morphine). Thus, the 6 groups 
used in this study were O-Vehicle, O-Morphine, 25-Vehicle, 25-Morphine, 50-Vehicle, and 
50-Morphine. Animals receiving morphine were administered daily ip injections of 10 mg/kg 
morphine sulfate expressed as the salt, while vehicle controls received saline (1. 0 ml/kg volume). 
In this initial phase of the project, animals were tested during 80 minute sessions each day for 21 
successive days, in squads of four, counterbalancing by group. The animal was placed in the 
chamber immediately following the injection, at which time the room lights were turned off. This 
procedure was employed in order to increase the discriminatory properties of the injections, 
Previous cocaine investigations (e. g. , Post et al. , 1981) have shown that contextual cues 
contribute to augmented responding associated with repeated drug administration. Insolhr as 
administering the injections, placement in the test chambers, turning off the test room lights and 
other pre-injection correlates serve in a feed-forward capacity, (as CSs), it is ~le to assume 
that reinstatement of such events could play an additive role in behavioral sensitization. We tested 
such a possibility by administering a vehicle only (0 mg/kg morphine) injection following initial 
sensitization testing (see procedures for Day 22 of testing). In all tests conducted in this study, 
total distance traveled (cm) was recorded post-injection across successive 5-min intervals for 80 
minutes. 
On Days 22-24, all animals within each of the three morphine-treated groups (0- 
Morphine, 25-Morphine, 50-Morphine) received successive daily injections of 0, 10, and 20 
mg/kg morphine. This range of morphine doses has been shown to be sufficient to characterize 
the complete dose-effect function produced by increasing doses of the drug (Nation, Miller, k. 
Livermore, 1997). Groups given vehicle injections (O-vehicle, 25-vehicle and 50-vehicle) 
continued to receive vehicle injections during this period. 
Following one day of interpolated morphine or vehicle exposure (Day 25), antagonist 
doses were administered in random order beginning on Day 26. All animals in all 6 groups 
received an injection of the antagonist (SCH 23390 or eticlopride) 30 minutes prior to 
administration of 10 mg/kg morphine or vehicle and were placed in the activity chamber 
immediately atter the morphine or vehicle injection. Antagonist injections were given in the 
home cage. SCH 23390 was admhtismred on Days 26, 28 and 30. The doses administered were 
. 01 mg/kg, . 056 mg/kg and . I mg/kg. Eticlopride was administered on Days 33, 35 and 37, with 
doses corresponding to those of SCH 23390. On the day following each dose of the antagonist, 
animals received only 10 mg/kg morphine or vehicle in order to ~lish baseline responding. 
During this period, at least one day of a vehicle (saline) pre-injection was administered in an 
effort to control for the possible development of cueing properties associated with the injection of 
the antagonisL Only with the administration of SCH 23390 was two days of morphine and 
vehicle exposure with a vehicle pre-injection required. 
Analysis of variance (ANOVA) tests were performed on the behavioral data. In all cases 
throughout this report, Neuman-Keuls procedure for examining significant mean differences was 
employed as the post hoc test. 
Results 
Bod Wei ht and Food Intake 
A two-way repeated measures analysis of variance (ANOVA) Exposure Condition (0, 25. 
50 ppm) x 6 Weeks (1-6) was performed to analyze possible differences in body weight and food 
intake among groups. A significant main effect of Exposure Group was found (F(2, 227)=268. 48, 
0&. 001). The main effect for Week also revealed an acceptable level for statistical significance 
(F(5, 227)=1482. 41, p&. 001). Also, body weights across all Exposure Conditions were 
significantly different from one another for all 6 Weeks (0&. 001). An interaction of Exposure 
Condition x Week was also found (F(10, 227)=31. 50, E&. 001). Subsequent post hoc analyses 
reveal that 25 ppm and 50 ppm cadmium exposed animals have significantly lower body weights 
than animals exposed to 0 ppm cadmium (p&. 001) for all Weeks except for Week 1. The body 
weights of animals exposed to 25 ppm cadmium and 50 ppm cadmium were not found to be 
significantly different, except on Week 5 and Week 6 (p&. 05), where it was observed that 50 ppm 
animals had lower body weights than 25 ppm mtimals. 
An identical ANOVA performed on food intake found a significant main effect of 
Exposure Condition (F(2, 227)=23. 36, g&. 001). Also, a significant main effect of Week was found 
(F(5, 227)= 83. 00, g&. 001). The results of ~on tests showed a statistically significant 
interaction of Exposum Condition x Week (F(10, 227)=83. 00, 0&. 001). Post Hoc analyses 
deternuned that food intake was significantly lower for the 25 ppm cadmium Exposure Condition 
(mean=177 g/week) and the 50 ppm cadmium Exposure Condition (mean=149 g/week) than for 
the 0 ppm cadmium Exposure Group (mean=194 g/week) (p&. 05). It was found that almost all 
cadmium Exposure Group (mean=194 g/week) (p&. 05). It was found that almost all 
weekly food intake values were significantly different from one another, with the 
exception of Week 5 and Week 6. 
Behavioral Data 
Figure 1 shows the mean total distance traveled for each exposure group across Days 1, 
7, 14 and 21, Figure 1 profiles behavioral sensitization in each of the morphine-exposure groups, 
with locomotor activity being reduced for all groups on Day 1, but gradually increasing across 
Days 7, 14 and 21. This sensitization effect was attenuated for those animals exposed to 25 and 
50 ppm cadmium. 
Statistical confirmation of the group separation apparent in Figure 1, was provided by 
the results of separate 2-way (Exposure Condition x Type of Injection) analysis of variance 
(ANOVA) tests performed on the data for Days I, 7, 14 and 21. These analyses revealed no 
significant main effects or interactions on Days 1, 7, and 14. However, on Day 21 a significant 
interaction effect of Exposure Condition x Type of Injection was found. (F(2, 32)= 4. 85, p&. 05) 
Post hoc tests revealed that animal treated with morphine and exposed to 50 ppm cadmium 
showed significantly less locomotor activity than morphine treated controls (p&. 05). Marginal 
differences in the same direction were shown for the comparison of group 0-morphine and group 
25-morphine (p=0. 051). 
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The results of the dose effect test (Days 22-24) across exposure groups are seen in Figure 
2. Administration of 0 mg/kg morphine (Day 22) resulted in no difference in locomotor activity 
across morphine-exposed groups or vehicle only groups. A dose effect was apparent, with 
locomotor activity being reduced relative to 10 mg/kg performances for all groups receiving an 
injection of 20 mg/kg morphine (F(2, 64)= 3. 95, 0&. 05). While there appears to be a trend for the 
0-Morphine group to show higher mean total distance traveled than the 25- Morphine and 50- 
Morphine group; results of a three-way ANOVA revealed no main effects or interactions across 
the three doses of morphine administered that mi~ indicate a separation of the 0-Morphine 
Exposure Condition and the 25-Morphine and 50-Morphine groups. . 
IWW 
j 440D 
~ DPI CDWI Vahlal mn ww c»wa 
Ianl lal» CDWU 




0 I»a 10 000 
0 MM~ 
D 000 0 ade DCMW 
0 dl W»U 
Rgum 2 Dose Effect Data cm 
Days 22-24. Maim (+ SEM) 
total distance traveled (cm) 
per daily session for vehicle 
and morphine-bested gmups 
at 0 mg/kg morphine, 10 
mg/kg oarflhirm aud 20 mg/kg 
morphine. Note: Vehicle- 
treated auuuals did uot receive 
morphine during dose effect 
tesuug. 
11 
Figure 3 depicts the average total distance traveled on those days during which the 
antagonist SCH 23390 was administered. Visual inspection of mean total distances of groups 
reveals that animals in both the vehicle and morphine groups that were exposed to 50 ppm 
cadmium consistently averaged lower total distance than those for the 0 ppm and 25 ppm 
conditions. Also, increasing doses of SCH 23390 effectively reduced locomotor activity for all 
animals across all groups. Statistical confirmations of these differences were provided in part by 
the finding of a marginally significant main effect for Exposure Condition (F(2, 32)= 2. 58, 31 &. 10) 
Because of the absence of significant interactions between Exposure Condition and Type of 
Injection, it would seem that this efFect resulted from decreased locomotor responding across both 
vehicle and morphine groups exposed to dams receiving 50 ppm cadmium. 
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Administration of increasing doses of eticlopride reduced locomotor activity for 25- 
Morphine and 50-Morphine Exposure groups (See Figure 4). 0-Morphine groups showed 
anonudous responding to the highest dose of antagonist, . I mg/kg, i. e. , an unexpected rebound 
effect was observed at this highest dose. ~on of figure 4 reveals no apparent differential 
sensitivity to doses of eticlopride among the 25- Morphine and 50-Morphine Exposure Groups. 
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A three-way ANOVA revealed a significant interaction effect (Dose x Exposure 
Condition x Type of Injection) for eticlopride administration (F(4, 64)=4. 88, n~ . 05). Post Hoc 
analyses indicated that the dose of eticlopride resulted in differential locomotor activity 
depending on the level of cadmium exposure and type of injection. As with SCH 23390, a 
marginal main effect of Exposure Condition was found (F(2, 32)=2. 67, p&. 1), suggesting that 
across both vehicle and morphine groups exposed to dams receiving 50 ppm cadmium. However, 
unlike the case for SCH 23390, the eticlopride data were not reliable across the range of doses 
tested here, 
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Discussion 
The findings fiem this study revealed that perinatd exposure to cadmium results in an 
attenuation of behavioral sensitization to morphine. This attenuation was observed as a decrease 
in mean locomotor activity across an 80 minute interval, and the cadmium-based antagonism of 
the locomotor-stimulating effects of morphine was most pmminently expressed on Day 21 by 
animals born to dams exposed to 50 ppm cadmium. ~ differences were observed for 
13 
group 25-Morphine on Day 21 as well. The finding of significantly lower locomotor activity 
among 50-Morphine animals indicates that behavioral sensitization was attenuated for this group. 
These data, as well as results from the SCH 23390 test, reveal a possible alteration in the 
neurotransmitter systems previously implicated in the development and expression of behavioral 
sensitization as a result of developmental cadmium exposure. Such an alteration could be the 
result of a decrease in DA receptor viability or function. Insofar as dopaminergic activity is 
integral to the expression of morphine sensitization (Jeziorski k White, 1995) and given that 
cadmium is an established dopamine antagonist (Olivier, Guibert 6't Liviel, 1995), the observed 
attenuation of cadmium is not altogether surprising. What is noteworthy is that this effect was 
observed during the adult cycle, long afier the exposure regiment was discontinued. Also, results 
from administration of SCH 23390 are instructive. Compromised DA levels resulting from a lack 
of dopamine receptors, or decreased receptor functionality, could explain the increased sensitivity 
of 50-Morphine animals to low doses of SCH 23390. That is, if functional DA receptors are 
reduced in these animals, any antagonistic effects exerted by SCH 23390, even at very low doses, 
would be amplified. Such effects could also explain the decreased locomotor activity of 50- 
Vehicle animals seen with the administration of SCH 23390, in comparison to 0-Vehicle and 25- 
Vehicle animals. For vehicle-treated animals, as well as morphine-treated animals, a decrease in 
functional receptors would result in more pronounced ~on of locomotor activity at lower 
doses of SCH 23390 compared to animah exposed to 0 ppm cadmium. 
Eticlopride data revealed significant interactions between the dose of eticlopride and 
cadmium pre~eat. The unusual response of the 0-Morphine animals across . 056 mg/kg and 
. I mg/kg doses of eticlopride, i. e. , an increase or rebound effect, points to the complexity of the 
differences in locomotor activity between the 0-Morphine groups and the 25-Morphine and 50- 
Morphine groups, Unlike the case for the contml animals, the trend for 25-Morphine and 50- 
Morphine groups was a decrease in locomotor activity with an increase in eticlopride dose. This 
14 
trend among metal-exposed animals, which was not apparent among the controls, is compatible 
with previous research indicating that eticlopride administration results in a decrease in the 
locomotor effects of behavioral sensitization (Jeziorski k. White, 1995). 
Along with the novel finding of the attenuation of behavioral sensitization to morphine 
for the 50-Morphine group, more general patterns of responsiveness to morphine administration 
were observed and these patterns are in agreement with previous findings. For instance, sedative 
properties of moiphine were observed, followed by a gradual development of the stimulatory 
properties of morphine ( Jeziorski et al. , 1994). One difference in the pattern of development of 
behavioral sensitization to morphine seen in all groups of developmental animals was a later 
onset of the stimulatory properties of morphine, relative to adult cases of cadmium exposure. In 
prior studies examining the effects of adult cadmium exposure to behavioral sensitization to 
morphine, behavioral sensitization was clearly established before Day 14 (Nation, Miller dk 
Livermore, 1997). In developmental studies, such as this one, behavioral sensitization was not 
clearly evident until Day 21. This delayed establishment of behavioral sensitization was evident 
in all animals including 0-Vehicle animals, indicating that this was not an idiosyncratic effect 
associated with cadmium exposure. 
Elsewhere, the dose effect data were consistent with previous findings (Nation, Miller 4 
Livermore, 1997). In this regard it is worth noting that responding to 0 mg/kg morphine was 
similar for cadmiumexposed and control animals. At this dose, it was also evident that 
contextual stimuli were not a factor in the increases in morphine-induced locomotor activity (test 
Day 22). At 10 mg/kg morphine, increased locomotor activity patterns were again evident, as 
seen with previous exposure to this dose of morphine. Here, there appears to be a tendency for 
both cadmium exposed groups to show attenuation of this increased locomotion, but statistical 
analyses yielded no significant main effects or interactions. Locomotor activity was decreased 
for aII animals that received a morphine injection at the dose of 20 mg/kg. 
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The finding of significant differences between the locomotor activity of animals exposed 
to cadmium indicates that the toxicant can alter pathways in the brain that are responsible for 
behavioral sensitization. The mechanism of this alteration is unclear and further research is 
necessary to explore the possibility of altered receptor viability or function. Investigation into 
how cadmium might alter the self administration of morphine is also of interest, as this would 
indicate an alteration in reward pathways thought to be responsible for drug taking and addictive 
behaviors. The levels of dopamine in the area of the NA are believed to be associated with the 
reinforcing effects of drug intake and previous research has shown that administration of 
antagonists lead to increased self-administration. (Nation, Livermore, Bratton il'c Schenk, 1996). 
Therefore, the antagonistic effects of cadmium could result in an increase in opiate use. This 
could prove to be of particular significance to portions of the population who smoke, resulting in 
increased health risks for smokers, and increased risks for the development of addictive 
behaviors, Regarding the implications of the present findings, it must be considered that 
developmental cadmium exposure, perhaps via mothers who smoke, could impact drug 
responsiveness of their progeny, possibly resulting in increased opiate use later in life. 
16 
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